Author Login IJIRT Partner Network (IPN) Login

The role of Gliclazide in metabolism

  • Unique Paper ID: 157232
  • Volume: 9
  • Issue: 6
  • PageNo: 399-401
  • Abstract:
  • Gliclazide is an oral antihyperglycemic agent which is used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). Gliclazide belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin molecules. Gliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70%) and feces (10-20%).
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 9
  • Issue: 6
  • PageNo: 399-401

The role of Gliclazide in metabolism

Related Articles

11 Nov, 2022

A review- Obesity & diabetic nephropathy

Read More
Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry